GTR 100677081
Tenders Are Invited For Pharmaceutical Products - Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For Active Substances (Drugs) - Vv 86
ICB — International Competitive Bid
Closes Aug 10, 2027
Western Europe
Tender Information
GTR Reference
100677081
Tendering Authority
Subscribe to view
Tender No
541953-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products - Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For Active Substances (Drugs) - Vv 86
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
10-08-2027
Work Detail
Pharmaceutical Products - Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For Active Substances (Drugs) - Vv 86. Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Finished Medicinal Product Acarizax-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Apixaban-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Apremilast-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Capsaicin (Quenza) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Ciclosporin (Ikervis) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Dexamethasone (Ozurdex) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Dupilumab-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Combination Emtrictabin/Rilpivirin/Tenofovir-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Felbamat-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Fluorouracil (Efudix) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Combination Glacaprivir/Pibrentasvir-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Finished Medicinal Product Itulazax-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Natalizumab (Ilo) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Olanzapine (Trs) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Ribociclib-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Rifaximin-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Roxadustat (Evrenzo) -Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Sirolimus-Vv 86,Completion Of Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Tafamidis-Vv 86
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
3d9f7073-126d-4dd0-9b8b-aed57062800c.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.